Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach
Keyhaneh Karimi, Edina Pallagi, Piroska Szabó‐Révész, et al.
Drug Design Development and Therapy (2016) Vol. Volume 10, pp. 3331-3343
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Novel strategies in the oral delivery of antidiabetic peptide drugs – Insulin, GLP 1 and its analogs
Ruba Ismail, Ildikó Csóka
European Journal of Pharmaceutics and Biopharmaceutics (2017) Vol. 115, pp. 257-267
Closed Access | Times Cited: 102
In Vitro Drug Release, Permeability, and Structural Test of Ciprofloxacin-Loaded Nanofibers
Luca Éva Uhljar, Sheng Yuan Kan, Norbert Radacsi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 556-556
Open Access | Times Cited: 81
A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications
Hend I. Shahin, Lipika Chablani
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104553-104553
Closed Access | Times Cited: 37
Ciprofloxacin-Loaded Inhalable Formulations against Lower Respiratory Tract Infections: Challenges, Recent Advances, and Future Perspectives
Vijay Kumar Panthi, Kathryn E. Fairfull‐Smith, Nazrul Islam
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 648-648
Open Access | Times Cited: 9
Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment
Ameeduzzafar Zafar, Nabil K. Alruwaili, Syed Sarim Imam, et al.
AAPS PharmSciTech (2020) Vol. 21, Iss. 5
Closed Access | Times Cited: 51
Preparation and Characterization of Ibuprofen Containing Nano-Embedded-Microparticles for Pulmonary Delivery
Petra Party, Márk László Klement, Piroska Szabó‐Révész, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 545-545
Open Access | Times Cited: 19
The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers
Francesca Buttini, Stavroula Rozou, Alessandra Rossi, et al.
European Journal of Pharmaceutical Sciences (2017) Vol. 113, pp. 64-76
Closed Access | Times Cited: 52
Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach
Gábor Katona, György Tibor Balogh, Gergő Dargó, et al.
Pharmaceutics (2020) Vol. 12, Iss. 2, pp. 97-97
Open Access | Times Cited: 48
Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance
Heba Banat, Rita Ambrus, Ildikó Csóka
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123070-123070
Closed Access | Times Cited: 16
Development of Ciprofloxacin-Loaded Electrospun Yarns of Application Interest as Antimicrobial Surgical Suture Materials
Jorge Teno, María Pardo-Figuerez, Zoran Evtoski, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 220-220
Open Access | Times Cited: 5
A quality-by-design strategic approach for the development of bedaquiline-pretomanid nanoparticles as inhalable dry powders for TB treatment
Suyash M. Patil, Alec M. Diorio, Parasharamulu Kommarajula, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123920-123920
Closed Access | Times Cited: 5
Extension of quality-by-design concept to the early development phase of pharmaceutical R&D processes
Ildikó Csóka, Edina Pallagi, T Paál
Drug Discovery Today (2018) Vol. 23, Iss. 7, pp. 1340-1343
Closed Access | Times Cited: 46
Initial Risk Assessment as part of the Quality by Design in peptide drug containing formulation development
Edina Pallagi, Ruba Ismail, T Paál, et al.
European Journal of Pharmaceutical Sciences (2018) Vol. 122, pp. 160-169
Closed Access | Times Cited: 43
Application of the QbD-based approach in the early development of liposomes for nasal administration
Edina Pallagi, Orsolya Jójárt‐Laczkovich, Zsófia Németh, et al.
International Journal of Pharmaceutics (2019) Vol. 562, pp. 11-22
Closed Access | Times Cited: 41
Development of Multilayer Ciprofloxacin Hydrochloride Electrospun Patches for Buccal Drug Delivery
Jorge Teno, María Pardo-Figuerez, Kelly J. Figueroa-López, et al.
Journal of Functional Biomaterials (2022) Vol. 13, Iss. 4, pp. 170-170
Open Access | Times Cited: 19
A Review on Recent Technologies for the Manufacture of Pulmonary Drugs
Gabriela Daisy Hadiwinoto, Philip Chi Lip Kwok, Richard Lakerveld
Therapeutic Delivery (2017) Vol. 9, Iss. 1, pp. 47-70
Closed Access | Times Cited: 36
Formulation of levodopa containing dry powder for nasal delivery applying the quality-by-design approach
Csilla Bartos, Edina Pallagi, Piroska Szabó‐Révész, et al.
European Journal of Pharmaceutical Sciences (2018) Vol. 123, pp. 475-483
Closed Access | Times Cited: 33
Pegylation and formulation strategy of Anti-Microbial Peptide (AMP) according to the quality by design approach
Reihaneh Manteghi, Edina Pallagi, Gábor Olajos, et al.
European Journal of Pharmaceutical Sciences (2019) Vol. 144, pp. 105197-105197
Closed Access | Times Cited: 32
An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development
Zsófia Németh, Edina Pallagi, Dorina Gabriella Dobó, et al.
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 1071-1071
Open Access | Times Cited: 25
Development of Ciprofloxacin-loaded Electrospun Fibre Yarns of Application Interest as Antimicrobial Surgical Suture Materials
Jorge Teno, María Pardo-Figuerez, Zoran Evtoski, et al.
(2024)
Open Access | Times Cited: 3
Ciprofloxacin-Loaded Spray-Dried Lactose Particles: Formulation Optimization and Antibacterial Efficacy
Sai Liu, Simon Gaisford, Gareth R. Williams
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 392-392
Open Access
Evolution and Advancements in Inhalation Therapy: A Comprehensive Review from Nebulizers to Dry Powder Inhalers
Mayur R Waje, Annasaheb S Gaikwad, Krishnaraj S. Rathod, et al.
Research Journal of Pharmacy and Technology (2025), pp. 436-444
Closed Access
Nanoparticle-Based Dry Powder Inhaler Containing Ciprofloxacin for Enhanced Targeted Antibacterial Therapy
Petra Party, Márk László Klement, Bianca Maria Gaudio, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 486-486
Open Access
Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties
Rita Ambrus, Edit Benke, Árpád Farkas, et al.
European Journal of Pharmaceutical Sciences (2018) Vol. 123, pp. 20-27
Open Access | Times Cited: 31
Preliminary study of nanonized lamotrigine containing products for nasal powder formulation
Péter Gieszinger, Ildikó Csóka, Edina Pallagi, et al.
Drug Design Development and Therapy (2017) Vol. Volume 11, pp. 2453-2466
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top